Abilify and Questran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Questran (cholestyramine). Common drug interactions include suicidal ideation among females and pancreatitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Questran. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

What is Questran?

Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.



On Aug, 01, 2026

26 people who take Abilify and Questran together, and have interactions are studied.

Abilify and Questran drug interactions.

What are the common drug interactions of Abilify and Questran, by gender? *:

female:

  1. Suicidal ideation
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Diabetes mellitus inadequate control
  5. Gestational diabetes (diabetes in pregnancy)
  6. Hyperglycaemia (high blood sugar)
  7. Psychotic disorder
  8. Type 1 diabetes mellitus
  9. Type 2 diabetes mellitus
  10. Weight increased

male:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Abdominal pain upper
  3. Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Myalgia (muscle pain)
  6. Neuropathy peripheral (surface nerve damage)
  7. Pancreatitis (inflammation of pancreas)
  8. Speech disorder
  9. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  10. Vomiting

What are the common drug interactions of Abilify and Questran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Application site discomfort
  2. Implant site pain

20-29:

  1. Suicidal ideation
  2. Diabetes mellitus inadequate control
  3. Gestational diabetes (diabetes in pregnancy)
  4. Hyperglycaemia (high blood sugar)
  5. Type 1 diabetes mellitus
  6. Type 2 diabetes mellitus
  7. Weight increased

30-39:

n/a

40-49:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Ammonia increased
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cholangitis sclerosing (infection and obstruction of bile duct)
  5. Coeliac disease (simple food intolerance)
  6. Confusional state
  7. Fatigue (feeling of tiredness)
  8. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  9. Hepatotoxicity (chemical-driven liver damage)
  10. Liver injury

50-59:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Diabetic nephropathy (diabetic kidney disease)
  3. Lipase increased
  4. Neuropathy peripheral (surface nerve damage)
  5. Pancreatitis (inflammation of pancreas)
  6. Sinusitis (inflammation of sinus)
  7. Vomiting
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Abdominal pain upper
  10. Blood cholesterol increased

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Psychotic disorder
  3. Chronic kidney disease
  4. Influenza
  5. Renal disorder (kidney disease)
  6. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 26.92%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 23.08%
  3. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 11.54%
  4. Multiple Myeloma (cancer of the plasma cells): 3 people, 11.54%
  5. Micturition Urgency (urgency to pass the urine): 3 people, 11.54%
  6. Cyst (a closed sac): 3 people, 11.54%
  7. Affective Disorder (mental disorder): 3 people, 11.54%
  8. Stress And Anxiety: 2 people, 7.69%
  9. High Blood Pressure: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Questran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Questran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and cholestyramine (the active ingredients of Abilify and Questran, respectively), and Abilify and Questran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: